Tenet Healthcare (THC) Stock Forecast & Price Target

Compare

867 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

THC Analyst Ratings

Strong Buy

15 Buy

2 Hold

0 Sell

Based on 17 analysts giving stock ratings to

Tenet

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

THC Stock 12 Month Forecast

Average Price Target

$184.71

▲(7.73%Upside)

Based on 17 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $184.71 with a high forecast of $230.00 and a low forecast of $137.00. The average price target represents a 7.73% change from the last price of $171.46.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"125":"$125","178":"$178","231":"$231","151.5":"$151.5","204.5":"$204.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":230,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$230.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":184.71,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$184.71</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":137,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$137.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[125,151.5,178,204.5,231],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,174.72615384615386,179.3323076923077,183.93846153846155,188.54461538461538,193.15076923076924,197.75692307692307,202.36307692307693,206.96923076923076,211.57538461538462,216.18153846153845,220.7876923076923,225.39384615384614,{"y":230,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,171.2423076923077,172.36461538461538,173.4869230769231,174.60923076923078,175.73153846153846,176.85384615384615,177.97615384615386,179.09846153846155,180.22076923076924,181.34307692307692,182.46538461538464,183.58769230769232,{"y":184.71,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,170.12,167.5723076923077,165.0246153846154,162.47692307692307,159.92923076923077,157.38153846153847,154.83384615384617,152.28615384615384,149.73846153846154,147.19076923076923,144.64307692307693,142.0953846153846,139.5476923076923,{"y":137,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":135.22,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.3,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.95,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":165.84,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.87,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.13,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":142.03,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.23,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.89,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.12,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$230.00

Average Price Target$184.71

Lowest Price Target$137.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$190

Buy

10.81%

Upside

Reiterated

06/06/25

Tenet Healthcare's strong operational efficiency and profitability metrics are the primary drivers of its stock score. The positive earnings momentum and strategic corporate events further bolster the score, despite valuation concerns and policy uncertainties posing potential risks.

Whit MayoLeerink Partners

Leerink Partners

$170→$209

Buy

21.89%

Upside

Reiterated

06/04/25

Leerink Partners Sticks to Its Buy Rating for Tenet Healthcare (THC)

Andrew Mok CFABarclays

Barclays

$171→$215

Buy

25.39%

Upside

Reiterated

06/03/25

Tenet Healthcare price target raised to $215 from $171 at BarclaysTenet Healthcare price target raised to $215 from $171 at Barclays

Stephen BaxterWells Fargo

Wells Fargo

$150→$195

Buy

13.73%

Upside

Upgraded

05/29/25

Positive Report for Tenet Healthcare (THC) from Wells Fargo

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$177

Buy

3.23%

Upside

Reiterated

05/28/25

Cantor Fitzgerald Keeps Their Buy Rating on Tenet Healthcare (THC)

Ann HynesMizuho Securities

Mizuho Securities

$170→$184

Buy

7.31%

Upside

Reiterated

05/20/25

Tenet Healthcare (THC) PT Raised to $184 at MizuhoMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $184.00 (from $170.00) while maintaining a Outperform rating.

Joanna GajukBank of America Securities

Bank of America Securities

$165→$180

Buy

4.98%

Upside

Reiterated

05/16/25

Tenet Healthcare (THC) PT Raised to $180 at BofA Securities following fireside chatBofA Securities analyst Joanna Gajuk raised the price target on Tenet Healthcare (NYSE: THC) to $180.00 (from $165.00) while maintaining a Buy rating.

Benjamin RossiJ.P. Morgan

J.P. Morgan

$190

Buy

10.81%

Upside

Reiterated

05/14/25

Analysts Are Bullish on Top Healthcare Stocks: Codexis (CDXS), Neurocrine (NBIX)

David S MacdonaldTruist Financial

Truist Financial

$175→$190

Buy

10.81%

Upside

Reiterated

05/12/25

Tenet Healthcare price target raised to $190 from $175 at TruistTenet Healthcare price target raised to $190 from $175 at Truist

Jamie PerseGoldman Sachs

Goldman Sachs

$134→$154

Hold

-10.18%

Downside

Reiterated

05/05/25

Tenet Healthcare (THC) PT Raised to $154 at Goldman SachsGoldman Sachs analyst Jamie Perse raised the price target on Tenet Healthcare (NYSE: THC) to $154.00 (from $134.00) while maintaining a Neutral rating.

A.J. RiceUBS

UBS

$217→$230

Buy

34.14%

Upside

Reiterated

04/30/25

Tenet Healthcare price target raised to $230 from $217 at UBSTenet Healthcare price target raised to $230 from $217 at UBS

Ben HendrixRBC Capital

RBC Capital

$183→$189

Buy

10.23%

Upside

Reiterated

04/30/25

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)

Matthew Gillmor CFAKeyBanc

KeyBanc

$185

Buy

7.90%

Upside

Reiterated

04/30/25

KeyBanc Remains a Buy on Tenet Healthcare (THC)

Jason CassorlaGuggenheim

Guggenheim

$165→$180

Buy

4.98%

Upside

Reiterated

04/29/25

Tenet Healthcare price target raised to $180 from $165 at GuggenheimTenet Healthcare price target raised to $180 from $165 at Guggenheim

Ryan LangstonTD Cowen

TD Cowen

$175

Buy

2.06%

Upside

Reiterated

04/29/25

Tenet Healthcare's Strong Performance and Strategic Focus Justify Buy Rating

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$190

Buy

10.81%

Upside

Reiterated

06/06/25

Whit MayoLeerink Partners

Leerink Partners

$170→$209

Buy

21.89%

Upside

Reiterated

06/04/25

Leerink Partners Sticks to Its Buy Rating for Tenet Healthcare (THC)

Andrew Mok CFABarclays

Barclays

$171→$215

Buy

25.39%

Upside

Reiterated

06/03/25

Tenet Healthcare price target raised to $215 from $171 at BarclaysTenet Healthcare price target raised to $215 from $171 at Barclays

Stephen BaxterWells Fargo

Wells Fargo

$150→$195

Buy

13.73%

Upside

Upgraded

05/29/25

Positive Report for Tenet Healthcare (THC) from Wells Fargo

Sarah JamesCantor Fitzgerald

Cantor Fitzgerald

$177

Buy

3.23%

Upside

Reiterated

05/28/25

Cantor Fitzgerald Keeps Their Buy Rating on Tenet Healthcare (THC)

Ann HynesMizuho Securities

Mizuho Securities

$170→$184

Buy

7.31%

Upside

Reiterated

05/20/25

Tenet Healthcare (THC) PT Raised to $184 at MizuhoMizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $184.00 (from $170.00) while maintaining a Outperform rating.

Joanna GajukBank of America Securities

Bank of America Securities

$165→$180

Buy

4.98%

Upside

Reiterated

05/16/25

Benjamin RossiJ.P. Morgan

J.P. Morgan

$190

Buy

10.81%

Upside

Reiterated

05/14/25

Analysts Are Bullish on Top Healthcare Stocks: Codexis (CDXS), Neurocrine (NBIX)

David S MacdonaldTruist Financial

Truist Financial

$175→$190

Buy

10.81%

Upside

Reiterated

05/12/25

Tenet Healthcare price target raised to $190 from $175 at TruistTenet Healthcare price target raised to $190 from $175 at Truist

Jamie PerseGoldman Sachs

Goldman Sachs

$134→$154

Hold

-10.18%

Downside

Reiterated

05/05/25

A.J. RiceUBS

UBS

$217→$230

Buy

34.14%

Upside

Reiterated

04/30/25

Tenet Healthcare price target raised to $230 from $217 at UBSTenet Healthcare price target raised to $230 from $217 at UBS

Ben HendrixRBC Capital

RBC Capital

$183→$189

Buy

10.23%

Upside

Reiterated

04/30/25

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (NASDAQ: ABVX), Atricure (NASDAQ: ATRC) and Tenet Healthcare (NYSE: THC)

Matthew Gillmor CFAKeyBanc

KeyBanc

$185

Buy

7.90%

Upside

Reiterated

04/30/25

KeyBanc Remains a Buy on Tenet Healthcare (THC)

Jason CassorlaGuggenheim

Guggenheim

$165→$180

Buy

4.98%

Upside

Reiterated

04/29/25

Tenet Healthcare price target raised to $180 from $165 at GuggenheimTenet Healthcare price target raised to $180 from $165 at Guggenheim

Ryan LangstonTD Cowen

TD Cowen

$175

Buy

2.06%

Upside

Reiterated

04/29/25

Tenet Healthcare's Strong Performance and Strategic Focus Justify Buy Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

1 Month

xxx

Success Rate

17/21 ratings generated profit

Average Return

+8.98%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 80.95% of your transactions generating a profit, with an average return of +8.98% per trade.

3 Months

xxx

Success Rate

25/35 ratings generated profit

Average Return

+10.31%

reiterated a xxx

rating 19 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +10.31% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

19/21 ratings generated profit

Average Return

+33.53%

reiterated a buy rating 27 days ago

Copying David S Macdonald's trades and holding each position for 1 Year would result in 90.48% of your transactions generating a profit, with an average return of +33.53% per trade.

2 Years

xxx

Success Rate

21/21 ratings generated profit

Average Return

+78.57%

reiterated a xxx

rating 27 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +78.57% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, THC has received 24 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. THC average Analyst price target in the past 3 months is 184.71.

Each month's total comprises the sum of three months' worth of ratings.

THC Financial Forecast

THC Earnings Forecast

Next quarter’s earnings estimate for THC is $2.87 with a range of $2.51 to $3.15. The previous quarter’s EPS was $4.36. THC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Sales Forecast

Next quarter’s sales forecast for THC is $5.16B with a range of $5.09B to $5.22B. The previous quarter’s sales results were $5.22B. THC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.49% of the time in the same period. In the last calendar year THC has Outperformed its overall industry.

THC Stock Forecast FAQ

What is THC’s average 12-month price target, according to analysts?

Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 184.71.

What is THC’s upside potential, based on the analysts’ average price target?

Tenet Healthcare has 7.73% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is THC a Buy, Sell or Hold?

Tenet Healthcare has a consensus rating of Strong Buy which is based on 15 buy ratings, 2 hold ratings and 0 sell ratings.

What is Tenet Healthcare’s price target?

The average price target for Tenet Healthcare is 184.71. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $230.00 ,the lowest forecast is $137.00. The average price target represents 7.73% Increase from the current price of $171.46.

What do analysts say about Tenet Healthcare?

Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.

How can I buy shares of THC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Tenet Healthcare (THC) Stock Forecast & Price Target

THC Analyst Ratings

THC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tenet Healthcare

THC Analyst Recommendation Trends

THC Financial Forecast

THC Earnings Forecast

THC Sales Forecast

THC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts